Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
-
Published:2024-06-01
Issue:8
Volume:30
Page:2189-2198
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Wang FengORCID, Shen Lin, Guo Weijian, Liu TianshuORCID, Li JinORCID, Qin Shukui, Bai Yuxian, Chen Zhendong, Wang Jufeng, Pan YueyinORCID, Shu Yongqian, Zhao Fuyou, Cheng Ying, Ye Feng, Gu Kangsheng, Zhang Tao, Pan Hongming, Zhong Haijun, Zhou Fuxiang, Qin Yanru, Yang Lei, Mao Weidong, Li Qiu, Dai Wenxiang, Li Wei, Wang Shubin, Tang Yong, Ma Dong, Yin Xianli, Deng Yanhong, Yuan YingORCID, Li Man, Hu Wenwei, Chen Donghui, Li GuoxinORCID, Liu Qiqi, Tan Panfeng, Fan Songhua, Shi Michael, Su Weiguo, Xu Rui-HuaORCID
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. World Health Organization. GLOBOCAN 2020. Population fact sheets, China. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf (2020). 2. World Health Organization. GLOBOCAN 2020. Cancer fact sheets, stomach. https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf (2020). 3. Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. eClinicalMedicine 47, 101404 (2022). 4. Manabe, N., Matsueda, K. & Haruma, K. Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries. Digestion 103, 29–36 (2022). 5. NCCN Guidelines. Gastric cancer. Version 3 https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (2023)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|